Attenuation of the hypothalamic-pituitary-adrenal axis responsivity to the Trier Social Stress Test by the benzodiazepine alprazolam

Psychoneuroendocrinology

Volumn 31, Issue 10, 2006, Pages 1278-1288

  Fries, Eva ^a,b   Hellhammer, Dirk H ^b   Hellhammer, Juliane ^a  

^a Daacro Clinical Research Organization   (Germany)

^b UNIVERSITY OF TRIER   (Germany)

Author keywords

Alprazolam; Benzodiazepine; Hypothalamic pituitary adrenal axis; State anxiety; Sympatho adrenomedullary system

Indexed keywords

ADRENALIN; ALPRAZOLAM; BENZODIAZEPINE; CORTICOTROPIN; HYDROCORTISONE; NORADRENALIN; PLACEBO;

ADULT; AGITATION; ANXIETY; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXPERIMENTAL TEST; HEART RATE; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MENTAL HEALTH; MENTAL STRESS; MOOD; NORMAL HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEDATION; SIDE EFFECT; SOCIAL PROBLEM; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TRIER SOCIAL STRESS TEST; WAKEFULNESS;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; AFFECT; ALPRAZOLAM; ANTI-ANXIETY AGENTS; BLOOD PRESSURE; DOUBLE-BLIND METHOD; EPINEPHRINE; HEART RATE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; NOREPINEPHRINE; PITUITARY-ADRENAL SYSTEM; PLACEBOS; PSYCHOLOGICAL TESTS; SALIVA; TEST ANXIETY SCALE; WAKEFULNESS;

EID: 33751258275     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2006.09.009     Document Type: Article

References (32)

1. Bali B., and Kovacs K.J. GABAergic control of neuropeptide gene expression in parvocellular neurons of the hypothalamic paraventricular nucleus. Eur. J. Neurosci. 18 (2003) 1518-1526
2. Bartanusz V., Muller D., Gaillard R.C., Streit P., Vutskits L., and Kiss J.Z. Local gamma-aminobutyric acid and glutamate circuit control of hypophyseotrophic corticotropin-releasing factor neuron activity in the paraventricular nucleus of the hypothalamus. Eur. J. Neurosci. 19 (2004) 777-782
3. Benschop R.J., Jacobs R., Sommer B., Schurmeyer T.H., Raab J.R., Schmidt R.E., and Schedlowski M. Modulation of the immunologic response to acute stress in humans by beta-blockade or benzodiazepines. FASEB J. 10 (1996) 517-524
4. Boudaba C., Szabo K., and Tasker J.G. Physiological mapping of local inhibitory inputs to the hypothalamic paraventricular nucleus. J. Neurosci. 16 (1996) 7151-7160
5. Breier A., Davis O., Buchanan R., Listwak S.J., Holmes C., Pickar D., and Goldstein D.S. Effects of alprazolam on pituitary-adrenal and catecholaminergic responses to metabolic stress in humans. Biol. Psychiatry 32 (1992) 880-890
6. Cullinan W.E. GABA(A) receptor subunit expression within hypophysiotropic CRH neurons: a dual hybridization histochemical study. J. Comp. Neurol. 419 (2000) 344-351
7. Decavel C., and Van den Pol A.N. GABA: a dominant neurotransmitter in the hypothalamus. J. Comp. Neurol. 302 (1990) 1019-1037
8. Dickerson S.S., and Kemeny M.E. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol. Bull. 130 (2004) 355-391
9. Gerra G., Zaimovic A., Zambelli U., Timpano M., Reali N., Bernasconi S., and Brambilla F. Neuroendocrine responses to psychological stress in adolescents with anxiety disorder. Neuropsychobiology 42 (2000) 82-92
10. Henry J.P. Biological basis of the stress response. Integr. Physiol. Behav. Sci. 27 (1992) 66-83
11. Herman J.P., Cullinan W.E., Ziegler D.R., and Tasker J.G. Role of the paraventricular nucleus microenvironment in stress integration. Eur. J. Neurosci. 16 (2002) 381-385
12. Herman J.P., Figueiredo H., Mueller N.K., Ulrich-Lai Y., Ostrander M.M., Choi D.C., and Cullinan W.E. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front. Neuroendocrinol. 24 (2003) 151-180
13. Hermes M.L., Coderre E.M., Buijs R.M., and Renaud L.P. GABA and glutamate mediate rapid neurotransmission from suprachiasmatic nucleus to hypothalamic paraventricular nucleus in rat. J. Physiol. 496 (1996) 749-757
14. Huppmann G., and Hellhammer D. Aspekte der Angst-Furcht-Differenzierung. Zeitschrift für klinische Psychologie und Psychotherapie 26 (1978) 115-127
15. Kalogeras K.T., Calogero A.E., Kuribayiashi T., Khan I., Gallucci W.T., Kling M.A., Chrousos G.P., and Gold P.W. In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: pharmacological and clinical implications. J. Clin. Endocrinol. Metab. 70 (1990) 1462-1471
16. Kirschbaum C., Pirke K.M., and Hellhammer D.H. The 'Trier Social Stress Test'-a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28 (1993) 76-81
17. Kovacs K.J., Miklos I.H., and Bali B. GABAergic mechanisms constraining the activity of the hypothalamo-pituitary-adrenocortical axis. Ann. N. Y. Acad. Sci. 1018 (2004) 466-476
18. Kudielka, B.M., Hellhammer, D., Kirschbaum, C., 2007a. Ten years of research with the Trier Social Stress Test (TSST)-revisited. In: Harmon-Jones, E., Winkielman, P. (Eds.), Social Neuroscience. Guilford Press, New York.
19. Kudielka, B.M., Wuest, S., Kirschbaum, C., Hellhammer, D., 2007b. The Trier Social Stress Test (TSST). In: Fink, G., Chrousos, G., Craig, I., de Kloet, E.R., Feuerstein, G., McEwen, B.S., Rose, N.R., Rubin, R.T., Steptoe, A. (Eds.), Encyclopedia of Stress, second revised ed. Elsevier, New York and Oxford.
20. Laux L., Glanzmann P., Schaffner P., and Spielberger C.D. State-Trait-Angst-Inventar STAI (1981), Weinheim, Beltz
21. Loewe B., Spitzer R.L., Zipfel S., and Herzog W. PHQ-D, Gesundheitsfragebogen fuer Patienten (2002), Karlsruhe, Pfizer
22. Mason J.W. A review of psychoendocrine research on the pituitary-adrenal cortical system. Psychosom. Med. 30 (1968) 576-607
23. Miklos I.H., and Kovacs K.J. GABAergic innervation of corticotropin-releasing hormone (CRH)-secreting parvocellular neurons and its plasticity as demonstrated by quantitative immunoelectron microscopy. Neuroscience 113 (2002) 581-592
24. Öhman A. Anxiety. In: Fink G. (Ed). Encyclopedia of Stress (2000), Academic Press, San Diego 226-231
25. Rohrer T., von Richthofen V., Schulz C., Beyer J., and Lehnert H. The stress-, but not corticotropin-releasing hormone-induced activation of the pituitary-adrenal axis in man is blocked by alprazolam. Horm. Metab. Res. 26 (1994) 200-206
26. Schommer N.C., Hellhammer D.H., and Kirschbaum C. Dissociation between reactivity of the hypothalamus-pituitary-adrenal axis and the sympathetic-adrenal-medullary system to repeated psychosocial stress. Psychosom. Med. 65 (2003) 450-460
27. Schulz P., Schlotz W., and Becker P. Trierer Inventar zum chronischen Stress (2004), Goettingen, Hogrefe
28. Smedes F., Kraak J.C., and Poppe H. Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine. J. Chromatogr. 231 (1982) 25-39
29. Steyer R., Schwenkmezger P., Notz P., and Eid M. Der Mehrdimensionale Befindlichkeitsfragebogen (1997), Goettingen, Hogrefe
30. Torpy D.J., Grice J.E., Hockings G.I., Walters M.M., Crosbie G.V., and Jackson R.V. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man. J. Clin. Endocrinol. Metab. 76 (1993) 388-391
31. Verster J.C., and Volkerts E.R. Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature. CNS Drug Rev. 10 (2004) 45-76
32. Zwanzger P., Eser D., Aicher S., Schule C., Baghai T.C., Padberg F., Ella R., Moller H.J., and Rupprecht R. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study. Neuropsychopharmacology 28 (2003) 979-984